Premier Direct/Healthier You
This article was originally published in The Tan Sheet
Executive Summary
Boca Raton, Fla. company relabeling its products as dietary supplements and submitting structure/function claims notifications to FDA in response to March 11 warning letter. The letter designates as unapproved new drug claims statements in catalogs for 10 of the company's products, including AHF Anti-homocysteine Formula, said to offer "Total freedom from heart attack, stroke or vascular disease," CoQ10-Forte, said to be "used regularly to treat most major heart conditions," and Clear Lungs, described as a Chinese herbal remedy for "the temporary relief of bronchial congestion due to emphysema, bronchitis, pneumonia, flu"
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning